HomeSTOK • NASDAQ
Follow
Stoke Therapeutics Inc
Previous close
$14.17
Day range
$12.20 - $14.25
Year range
$3.35 - $16.40
Market cap
625.10M USD
Avg Volume
1.65M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 3.31M | 13.87% |
Operating expense | 30.54M | 1.63% |
Net income | -24.54M | 6.01% |
Net profit margin | -741.90 | 17.46% |
Earnings per share | -0.55 | 16.67% |
EBITDA | -26.60M | 0.61% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 214.72M | -14.68% |
Total assets | 239.89M | -13.59% |
Total liabilities | 66.89M | -8.97% |
Total equity | 173.00M | — |
Shares outstanding | 44.65M | — |
Price to book | 3.62 | — |
Return on assets | -27.41% | — |
Return on capital | -36.76% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -24.54M | 6.01% |
Cash from operations | -17.26M | 21.74% |
Cash from investing | 14.62M | -78.27% |
Cash from financing | 562.00K | 29.49% |
Net change in cash | -2.08M | -104.56% |
Free cash flow | -7.32M | 34.02% |
About
Founded
2014
Headquarters
Website
Employees
110